World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
9504
World Ranking
14599
National Ranking
514

Chemistry

D-Index
51
Citations
7981
World Ranking
14115
National Ranking
380

Richard Leduc publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Richard Leduc sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 170 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Richard Leduc D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Leduc sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 51 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Richard Leduc is affiliated with the Université de Sherbrooke in Canada. Their research spans several fields primarily within Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on Molecular Biology, Infectious Diseases, and Epidemiology.

Leduc's work extensively covers topics related to SARS-CoV-2 and COVID-19 research, including COVID-19 clinical studies, computational drug discovery methods, receptor mechanisms and signaling. Their research also includes influenza virus studies, neuropeptides and animal physiology, as well as vaccines and immunoinformatics approaches.

Frequent co-authors collaborating with Leduc include Pierre-Luc Boudreault, Antoine Désilets, François Jean, Gabriel Lemieux, and Malihe Hassanzadeh.

Common publication venues for their research include bioRxiv (Cold Spring Harbor Laboratory), Antiviral Research, Journal of Medicinal Chemistry, ChemMedChem, and Nature Communications.

Notable recent papers authored by or involving Leduc are:

  • A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic, 2022, Nature
  • Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature, 2020, Expert Opinion on Therapeutic Patents
  • Unraveling allostery within the angiotensin II type 1 receptor for Gα q and β-arrestin coupling, 2023, Science Signaling
  • Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility, 2022, Molecular Psychiatry
  • Killer whales preying on a blue whale calf on the Costa Rica Dome: genetics, morphometrics, vocalisations and composition of the group, 2023, The journal of cetacean research and management. Special issue

Best Publications

  • Processing of transforming growth factor beta 1 precursor by human furin convertase.

    Claire M. Dubois;Marie-Hélène Laprise;François Blanchette;Larry E. Gentry

  • KEX2-LIKE ENDOPROTEASES PC2 AND PC3 ACCURATELY CLEAVE A MODEL PROHORMONE IN MAMMALIAN CELLS : EVIDENCE FOR A COMMON CORE OF NEUROENDOCRINE PROCESSING ENZYMES

    Laurel Thomas;Richard Leduc;Barbara A. Thorne;Steven P. Smeekens

  • Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.

    Robert P.T. Somerville;Jean-Michel Longpre;Katherine A. Jungers;J. Michael Engle

  • Evidence that Furin Is an Authentic Transforming Growth Factor-β1-Converting Enzyme

    Claire M. Dubois;François Blanchette;Marie-Hélène Laprise;Richard Leduc

  • A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

    Unknown

  • Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage.

    R Leduc;S S Molloy;B A Thorne;G Thomas

  • Subtilase-like pro-protein convertases: from molecular specificity to therapeutic applications.

    Unknown

  • Characterization of METH-1/ADAMTS1 Processing Reveals Two Distinct Active Forms

    Juan Carlos Rodrı́guez-Manzaneque;Allison B. Milchanowski;Erick K. Dufour;Richard Leduc

  • Ligand-Induced Signaling in the Absence of Furin Processing of Notch1

    Guy diSibio;Alison Miyamoto;Jean-Bernard Denault

  • Processing of proendothelin-1 by human furin convertase

    Jean-Bernard Denault;Audrey Claing;Pedro D'Orléans-Juste;Tatsuya Sawamura

  • Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors

    Yoon Namkung;Christian LeGouill;Sahil Kumar;Yubo Cao

  • Characterization of proADAMTS5 processing by proprotein convertases.

    Jean Michel Longpré;Daniel R. McCulloch;Bon Hun Koo;J. Preston Alexander

  • A Polyaromatic Caveolin-Binding-Like Motif in the Cytoplasmic Tail of the Type 1 Receptor for Angiotensin II Plays an Important Role in Receptor Trafficking and Signaling

    Patrice C. Leclerc;Mannix Auger-Messier;Pascal M. Lanctot;Emanuel Escher

  • Polyethylene Glycol Conjugation at Cys232 Prolongs the Half-Life of α1 Proteinase Inhibitor

    André M. Cantin;Donald E. Woods;Diane Cloutier;Erick K. Dufour

  • ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domain.

    Robert P T Somerville;Jean Michel Longpré;Elizabeth D. Apel;Renate M. Lewis

  • Inhibitory Potency and Specificity of Subtilase-like Pro-protein Convertase (SPC) Prodomains

    Martin Fugère;Polizois C. Limperis;Véronique Beaulieu-Audy;Frédéric Gagnon

  • Discovery and Structure–Activity Relationship of a Bioactive Fragment of ELABELA that Modulates Vascular and Cardiac Functions

    Alexandre Murza;Xavier Sainsily;David Coquerel;Jérôme Côté

  • Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties

    Michel Demeule;Nicolas Beaudet;Anthony Régina;Élie Besserer-Offroy

  • Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides.

    François Béliveau;Antoine Désilets;Richard Leduc

  • The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.

    S A Laporte;G Servant;D E Richard;E Escher

  • The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS

    Stéphanie Gravel;Camille Malouf;Philip E. Boulais;Yamina A. Berchiche

  • Role of N-glycosylation in the expression and functional properties of human AT1 receptor.

    Pascal M. Lanctôt;Patrice C. Leclerc;Emanuel Escher;Richard Leduc

Frequent Co-Authors

Philippe Sarret
Philippe Sarret Université de Sherbrooke
Claude Lazure
Claude Lazure University of Montreal
Suneel S. Apte
Suneel S. Apte Case Western Reserve University
Andrew D. Rowan
Andrew D. Rowan Newcastle University
Nabil G. Seidah
Nabil G. Seidah University of Montreal
Robin Plevin
Robin Plevin University of Strathclyde
Marie-Pierre Dubé
Marie-Pierre Dubé Montreal Heart Institute
Laurent Prézeau
Laurent Prézeau University of Montpellier
Robert Day
Robert Day Université de Sherbrooke
Tim E. Cawston
Tim E. Cawston Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard Leduc

Trending Scientists

Recently Published Articles